A detailed history of L.M. Kohn & Company transactions in Zoetis Inc. stock. As of the latest transaction made, L.M. Kohn & Company holds 1,408 shares of ZTS stock, worth $274,222. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,408
Previous 1,414 0.42%
Holding current value
$274,222
Previous $239,000 2.09%
% of portfolio
0.07%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$145.54 - $178.83 $873 - $1,072
-6 Reduced 0.42%
1,408 $244,000
Q1 2024

Apr 25, 2024

BUY
$165.67 - $199.94 $14,744 - $17,794
89 Added 6.72%
1,414 $239,000
Q4 2023

Feb 09, 2024

BUY
$151.44 - $200.09 $15,144 - $20,009
100 Added 8.16%
1,325 $261,000
Q2 2023

Aug 08, 2023

BUY
$160.94 - $186.23 $1,448 - $1,676
9 Added 0.74%
1,225 $210,000
Q1 2023

May 08, 2023

BUY
$145.48 - $175.02 $176,903 - $212,824
1,216 New
1,216 $202,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $91.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track L.M. Kohn & Company Portfolio

Follow L.M. Kohn & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of L.M. Kohn & Company, based on Form 13F filings with the SEC.

News

Stay updated on L.M. Kohn & Company with notifications on news.